Ingredion (NYSE:INGR) Downgraded by Wall Street Zen to “Hold”

Ingredion (NYSE:INGR) was downgraded by equities research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Saturday.

A number of other equities research analysts also recently commented on the company. Industrial Alliance Securities set a $124.00 price objective on Ingredion in a research report on Thursday, November 6th. Oppenheimer set a $136.00 price target on Ingredion in a research note on Wednesday, October 22nd. Barclays restated an “equal weight” rating and issued a $124.00 price target (down previously from $168.00) on shares of Ingredion in a report on Thursday, November 6th. Zacks Research upgraded shares of Ingredion from a “strong sell” rating to a “hold” rating in a report on Monday, December 22nd. Finally, BMO Capital Markets decreased their target price on shares of Ingredion from $143.00 to $123.00 and set a “market perform” rating on the stock in a research report on Wednesday, November 5th. One research analyst has rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $124.33.

Ingredion Stock Performance

NYSE:INGR opened at $118.20 on Friday. The company has a debt-to-equity ratio of 0.41, a current ratio of 2.75 and a quick ratio of 1.79. The firm has a market cap of $7.51 billion, a PE ratio of 11.78, a P/E/G ratio of 0.94 and a beta of 0.72. The firm has a 50 day simple moving average of $111.68 and a 200-day simple moving average of $118.77. Ingredion has a 1-year low of $102.31 and a 1-year high of $141.78.

Ingredion (NYSE:INGR) last released its earnings results on Tuesday, November 4th. The company reported $2.75 EPS for the quarter, topping the consensus estimate of $2.73 by $0.02. The firm had revenue of $1.82 billion during the quarter, compared to analysts’ expectations of $1.90 billion. Ingredion had a net margin of 9.07% and a return on equity of 18.14%. Ingredion has set its FY 2025 guidance at 11.100-11.300 EPS. On average, equities analysts expect that Ingredion will post 11.14 EPS for the current year.

Institutional Trading of Ingredion

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Integrated Wealth Concepts LLC raised its holdings in Ingredion by 32.8% in the first quarter. Integrated Wealth Concepts LLC now owns 2,082 shares of the company’s stock valued at $281,000 after buying an additional 514 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Ingredion by 63.9% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 3,694 shares of the company’s stock worth $499,000 after acquiring an additional 1,440 shares in the last quarter. NewEdge Advisors LLC increased its position in shares of Ingredion by 9.0% in the first quarter. NewEdge Advisors LLC now owns 9,687 shares of the company’s stock worth $1,310,000 after acquiring an additional 797 shares in the last quarter. Goldman Sachs Group Inc. raised its stake in shares of Ingredion by 5.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 101,414 shares of the company’s stock valued at $13,712,000 after acquiring an additional 5,255 shares during the period. Finally, Focus Partners Wealth lifted its holdings in shares of Ingredion by 5.6% during the 1st quarter. Focus Partners Wealth now owns 3,636 shares of the company’s stock valued at $492,000 after acquiring an additional 192 shares in the last quarter. Institutional investors and hedge funds own 85.27% of the company’s stock.

Ingredion Company Profile

Ingredion Incorporated is a global ingredient solutions company specializing in the production and sale of starches, sweeteners, nutrition ingredients and biomaterials derived primarily from corn and other plant-based raw materials. The company serves a diverse set of industries, including food and beverage, brewing, pharmaceuticals and personal care, providing functional ingredients that enhance texture, stability, flavor and nutritional value in a wide array of end products.

The company’s product portfolio comprises native and modified starches, high-fructose corn syrup, dextrose, maltodextrins, specialty sweeteners and various texturizers.